{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:03:37Z","timestamp":1786982617156,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465687\/2014-8"],"award-info":[{"award-number":["465687\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["16\/2551-0000467-6"],"award-info":[{"award-number":["16\/2551-0000467-6"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2014\/50928-2"],"award-info":[{"award-number":["2014\/50928-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13346-020-00813-5","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T13:03:59Z","timestamp":1597237439000},"page":"1700-1715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intranasal administration of budesonide-loaded nanocapsule microagglomerates as an innovative strategy for asthma treatment"],"prefix":"10.1007","volume":"10","author":[{"given":"Manoel","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"de Sa Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Torres","family":"Ciambarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everton Tenorio","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Leite","family":"D\u2019Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta\u00eds Lusa","family":"Durli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Machado","family":"Rodrigues e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andressa","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Sonvico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-1807","authenticated-orcid":false,"given":"Adriana Raffin","family":"Pohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Aurelio","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-6826","authenticated-orcid":false,"given":"S\u00edlvia Stanis\u00e7uaski","family":"Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"813_CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","volume":"454","author":"SJ Galli","year":"2008","unstructured":"Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454:445\u201354.","journal-title":"Nature."},{"key":"813_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1183\/09031936.00053506","volume":"29","author":"ED Fixman","year":"2007","unstructured":"Fixman ED, Stewart A, Martin JG. Basic mechanisms of development of airway structural changes in asthma. Eur Respir J. 2007;29:379\u201389.","journal-title":"Eur Respir J"},{"key":"813_CR3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2222.2008.02971.x","volume":"38","author":"ST Holgate","year":"2008","unstructured":"Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008;38:872\u201397.","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"813_CR4","first-page":"327","volume":"18","author":"J Mullol","year":"2008","unstructured":"Mullol J, Valero A, Alobid I, Bartra J, Navarro AM, Chivato T, et al. Allergic rhinitis and its impact on asthma update (ARIA 2008), the perspective from Spain. J Investig Allergol Clin Immunol. 2008;18(5):327\u201334.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"813_CR5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/all.12124","volume":"68","author":"S Lohia","year":"2013","unstructured":"Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68:569\u201379.","journal-title":"Allergy."},{"key":"813_CR6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/bmj.317.7173.1624","volume":"317","author":"JM Weiner","year":"1998","unstructured":"Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998;317:1624\u20139.","journal-title":"BMJ."},{"key":"813_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10717544.2014.920431","volume":"23","author":"A Kumar","year":"2014","unstructured":"Kumar A, Pandey AN, Jain SK. Nasal nanotechnology: revolution for efficient therapeutics delivery. Drug Deliv. 2014;23:671\u201383.","journal-title":"Drug Deliv"},{"key":"813_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pupt.2016.07.001","volume":"40","author":"G Pelaia","year":"2016","unstructured":"Pelaia G, Vatrella A, Busceti MT, Fabiano F, Terracciano R, Matera MG, et al. Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma. Pulm Pharmacol Ther. 2016;40:15\u201321.","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"813_CR9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0149-2918(04)90050-1","volume":"26","author":"BE Stanaland","year":"2004","unstructured":"Stanaland BE. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Clin Ther. 2004;26(4):473\u201392.","journal-title":"Clin Ther"},{"key":"813_CR10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2017.09.027","volume":"113","author":"L Tiozzo Fasiolo","year":"2018","unstructured":"Tiozzo Fasiolo L, Manniello MD, Tratta E, Buttini F, Rossi A, Sonvico F, et al. Opportunity and challenges of nasal powders: drug formulation and delivery. Eur J Pharm Sci. 2018;113:2\u201317.","journal-title":"Eur J Pharm Sci"},{"key":"813_CR11","doi-asserted-by":"publisher","unstructured":"Sonvico F, Clementino A, Buttini F, Colombo G, Pescina S, Guterres SS, et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharmaceutics. 2018;10. https:\/\/doi.org\/10.3390\/pharmaceutics10010034.","DOI":"10.3390\/pharmaceutics10010034"},{"key":"813_CR12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.colsurfa.2013.04.015","volume":"431","author":"LA Fiel","year":"2013","unstructured":"Fiel LA, Adorne MD, Guterres SS, Netz PA, Pohlmann AR. Variable temperature multiple light scattering analysis to determine the enthalpic term of a reversible agglomeration in submicrometric colloidal formulations: a quick quantitative comparison of the relative physical stability. Colloids Surf A Physicochem Eng Asp. 2013;431:93\u2013104.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"813_CR13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1166\/jbn.2009.1004","volume":"5","author":"E Jager","year":"2009","unstructured":"Jager E, Venturini CG, Poletto FS, Colome LM, Pohlmann JP, Bernardi A, et al. Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J Biomed Nanotechnol. 2009;5:130\u201340.","journal-title":"J Biomed Nanotechnol"},{"key":"813_CR14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.colsurfa.2010.12.011","volume":"375","author":"CG Venturini","year":"2011","unstructured":"Venturini CG, Jager E, Oliveira CP, Bernardi A, Battastini AMO, Guterres SS, et al. Formulation of lipid core nanocapsules. Colloids Surf A Physicochem Eng Asp. 2011;375:200\u20138.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"813_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S0103-97332009000200013","volume":"39","author":"SS Guterres","year":"2009","unstructured":"Guterres SS, Beck RCR, Pohlmann AR. Spray-drying technique to prepare innovative nanoparticulated formulations for drug administration: a brief overview. Braz J Phys. 2009;39:205\u20139.","journal-title":"Braz J Phys"},{"issue":"3","key":"813_CR16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.etap.2012.07.009","volume":"34","author":"U Deb","year":"2012","unstructured":"Deb U, Lomash V, Raghuvanshi S, Pant SC, Vijayaraghavan R. Effects of 28 days silicon dioxide aerosol exposure on respiratory parameters, blood biochemical variables and lung histopathology in rats. Environ Toxicol Pharmacol. 2012;34(3):977\u201384.","journal-title":"Environ Toxicol Pharmacol"},{"key":"813_CR17","unstructured":"Guterres SS, Pohlmann AR, Beck RCR, Dimer FA, Ortiz M. Processo one-pot de s\u00edntese de nanoc\u00e1psulas polim\u00e9ricas, suas formas secas, composi\u00e7\u00f5es farmac\u00eauticas de nanoc\u00e1psulas polim\u00e9ricas e seus usos. Patent application INPI BR 102013019136-1 A2; 2013."},{"key":"813_CR18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejps.2006.10.006","volume":"30","author":"P Tewa-Tagne","year":"2007","unstructured":"Tewa-Tagne P, Briancon S, Fessi H. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterization. Eur J Pharm Sci. 2007;30:124\u201335.","journal-title":"Eur J Pharm Sci"},{"key":"813_CR19","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1002\/jps.21630","volume":"98","author":"N El-Gendy","year":"2009","unstructured":"El-Gendy N, Gorman EM, Munson EJ, Berkland C. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009;98:2731\u201346.","journal-title":"J Pharm Sci"},{"key":"813_CR20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2017.00740","volume":"8","author":"DS Coutinho","year":"2017","unstructured":"Coutinho DS, Anjos-Valotta EA, do Nascimento C, Pires ALA, Napimoga MH, Carvalho VF, et al. 15-Deoxy-Delta-12,14-Prostaglandin J2 Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma. Front. Immunol. 2017;8:740.","journal-title":"Front. Immunol"},{"key":"813_CR21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/ALN.0b013e31826687d5","volume":"117","author":"MF Serra","year":"2012","unstructured":"Serra MF, Anjos-Valotta EA, Olsen PC, Couto GC, Jurgilas PB, Cotias AC, et al. Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma. Anesthesiology. 2012;117:580\u201391.","journal-title":"Anesthesiology."},{"issue":"3","key":"813_CR22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.intimp.2013.08.008","volume":"17","author":"CPS Subhashini","year":"2013","unstructured":"Subhashini CPS, Kumari S, Kumar JP, Chawla R, Dash D, Singh M, et al. Intranasal curcumin and its evaluation in murine model of asthma. Int Immunopharmacol. 2013;17(3):733\u201343.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"813_CR23","first-page":"5505","volume":"7","author":"W Wu","year":"2014","unstructured":"Wu W, Chen H, Li YM, Wang SY, Diao X, Liu KG. Intranasal siRNA targeting c-kit reduces airway inflammation in experimental allergic asthma. Int J Clin Exp Pathol. 2014;7(9):5505\u201314.","journal-title":"Int J Clin Exp Pathol"},{"key":"813_CR24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/187221112802652651","volume":"6","author":"RCR Beck","year":"2012","unstructured":"Beck RCR, Ourique AF, Guterres SS, Pohlmann AR. Spray-dried polymeric nanoparticles for pharmaceutics: a review of patents. Recent Pat Drug Deliv Formul. 2012;6:195\u2013208.","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"813_CR25","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1039\/c2sm25754h","volume":"8","author":"DS Jornada","year":"2012","unstructured":"Jornada DS, Fiel LA, Bueno K, Gerent JF, Petzhold CL, Beck RCR, et al. Lipid-core nanocapsules: mechanism of self-assembly, control of size and loading capacity. Soft Matter. 2012;8:6646\u201355.","journal-title":"Soft Matter"},{"key":"813_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2004.07.027","volume":"285","author":"AR Najafabadi","year":"2004","unstructured":"Najafabadi AR, Gilani K, Barghi M, Rafiee-Tehrani M. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine. Int J Pharm. 2004;285:97\u2013108.","journal-title":"Int J Pharm"},{"key":"813_CR27","first-page":"897","volume":"6","author":"FQ Li","year":"2011","unstructured":"Li FQ, Yan C, Bi J, Lv WL, Ji RR, Chen X, et al. A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets. Int J Nanomedicine. 2011;6:897\u2013904.","journal-title":"Int J Nanomedicine"},{"key":"813_CR28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaerosci.2007.04.005","volume":"38","author":"R Vehring","year":"2007","unstructured":"Vehring R, Foss WR, Lechuga-Ballesteros D. Particle formation in spray drying. J Aerosol Sci. 2007;38:728\u201346.","journal-title":"J Aerosol Sci"},{"key":"813_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.12.040","volume":"406","author":"TC Carvalho","year":"2011","unstructured":"Carvalho TC, Peters JI, Williams RO 3rd. Influence of particle size on regional lung deposition-what evidence is there? Int J Pharm. 2011;406:1\u201310.","journal-title":"Int J Pharm"},{"issue":"12","key":"813_CR30","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","volume":"39","author":"A Sosnik","year":"2014","unstructured":"Sosnik A. das Neves J, Sarmento, B. Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review. Prog Polym Sci. 2014;39(12):2030\u201375.","journal-title":"Prog Polym Sci"},{"key":"813_CR31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00011-009-0054-2","volume":"58","author":"Gueders","year":"2009","unstructured":"Gueders, et al. Mouse models of asthma: a comparison between C57BL\/6 and BALB\/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflamm. Res. 2009;58:845\u201354.","journal-title":"Inflamm. Res"},{"key":"813_CR32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ng1095-150","volume":"11","author":"GT De Sanctis","year":"1995","unstructured":"De Sanctis GT, Merchant M, Beier DR, Dredge RD, Grobholz JK, Martin TR, et al. Quantitative locus analysis of airway hyperresponsiveness in A\/J and C57BL\/6J mice. Nat Genet. 1995;11:150\u20134.","journal-title":"Nat Genet"},{"key":"813_CR33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.1700933","volume":"201","author":"MF Serra","year":"2018","unstructured":"Serra MF, Cotias AC, Pao CRR, Daleprane JB, Jurgilas PB, Couto GC, et al. Repeated allergen exposure in A\/J mice causes steroid-insensitive asthma via a defect in glucocorticoid receptor bioavailability. J Immunol. 2018;201:851\u201360.","journal-title":"J Immunol"},{"key":"813_CR34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/rccm.200210-1188OC","volume":"168","author":"K Shinagawa","year":"2003","unstructured":"Shinagawa K, Kojima M. Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med. 2003;168:959\u201367.","journal-title":"Am J Respir Crit Care Med"},{"key":"813_CR35","doi-asserted-by":"crossref","first-page":"105819","DOI":"10.1016\/j.rmed.2019.105819","volume":"160","author":"A Matucci","year":"2019","unstructured":"Matucci A, Maggi E, Vultaggio A. Eosinophils, the IL-5\/IL-5Ralpha axis, and the biologic effects of benralizumab in severe asthma. Respir Med. 2019;160:105819.","journal-title":"Respir Med"},{"issue":"5","key":"813_CR36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/labinvest.3780068","volume":"80","author":"PS Foster","year":"2000","unstructured":"Foster PS, Ming Y, Matthei KI, Young IG, Temelkovski J, Kumar RK. Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab Investig. 2000;80(5):655\u201362.","journal-title":"Lab Investig"},{"issue":"10","key":"813_CR37","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1164\/rccm.200306-855OC","volume":"169","author":"G Dent","year":"2004","unstructured":"Dent G, Hadjicharalambous C, Yoshikawa T, Handy RL, Powell J, Anderson IK, et al. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum. Am J Respir Crit Care Med. 2004;169(10):1110\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"813_CR38","doi-asserted-by":"crossref","first-page":"1802250","DOI":"10.1183\/13993003.02250-2018","volume":"53","author":"P Nair","year":"2019","unstructured":"Nair P, O'Byrne PM. The interleukin-13 paradox in asthma: effective biology, ineffective biologicals. Eur Respir J. 2019;53(2):1802250.","journal-title":"Eur Respir J"},{"issue":"12","key":"813_CR39","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365(12):1088\u201398.","journal-title":"N Engl J Med"},{"issue":"8","key":"813_CR40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","volume":"70","author":"NA Hanania","year":"2015","unstructured":"Hanania NA, Noonan M, Corren J, Korenblat P, Zheng Y, Fischer SK, et al. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 2015;70(8):748\u201356.","journal-title":"Thorax."},{"key":"813_CR41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/ACI.0b013e32833363b2","volume":"10","author":"TR Bai","year":"2010","unstructured":"Bai TR. Evidence for airway remodeling in chronic asthma. Curr Opin Allergy Clin Immunol. 2010;10:82\u20136.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"813_CR42","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(06)69288-X","volume":"368","author":"ST Holgate","year":"2006","unstructured":"Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet. 2006;368:780\u201393.","journal-title":"Lancet."},{"key":"813_CR43","first-page":"357","volume":"9","author":"ER Walsh","year":"2010","unstructured":"Walsh ER, Stokes K, August A. The role of eosinophils in allergic airway inflammation. Discov Med. 2010;9:357\u201362.","journal-title":"Discov Med"},{"key":"813_CR44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.20071840","volume":"205","author":"EA Jacobsen","year":"2008","unstructured":"Jacobsen EA, Ochkur SI, Pero RS, Taranova AG, Protheroe CA, Colbert DC, et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med. 2008;205:699\u2013710.","journal-title":"J Exp Med"},{"issue":"4","key":"813_CR45","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1208\/s12249-018-0968-5","volume":"19","author":"PS Chaves","year":"2018","unstructured":"Chaves PS, Frank LA, Frank AG, Pohlmann AR, Guterres SS, Beck RC. Mucoadhesive properties of Eudragit\u00aeRS100, Eudragit\u00aeS100, and poly(\u03b5-caprolactone) nanocapsules: influence of the vehicle and the mucosal surface. AAPS PharmSciTech. 2018;19(4):1637\u201346.","journal-title":"AAPS PharmSciTech"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00813-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00813-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00813-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T19:36:38Z","timestamp":1628710598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-020-00813-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00813-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"12 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Diego de Sa Coutinho, Bianca Torres Ciambarella, Everton Tenorio de Souza, Ana Paula Leite D\u2019Almeida, Ta\u00eds Lusa Durli, Patr\u00edcia Machado Rodrigues e Silva, Andressa Bernardi, Fabio Sonvico, and Marco Aurelio Martins declare that they have no conflict of interest. Manoel Ortiz, Adriana Raffin Pohlmann, and Silvia Stanis\u00e7uaski Guterres have the potential conflict of interest because of a patent application related to the topic of the study (INPI BR 102013019136-1 A2; 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}